Walmart, CVS, Amazon, and Costco Could Win the GLP-1 Market as Employers Drop Coverage

Major retailers such as Amazon, CVS, Costco, and Walmart could end up snagging the lion’s share of the GLP-1 weight-loss drug market as American employers drop coverage for these medications. “Retailers are betting that if they can become the front door for obesity care, they’ll earn a relationship that extends far beyond a single GLP-1 prescription,” said Eric Bormel of Solomon Partners’ healthcare group (more).